Craig Mowat

Academic, Clinical Sen Lecturer/Honorary Cons (Teaching and Research)

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Craig Mowat is an Academic Clinical Senior Lecturer and Honorary Consultant at the University of Dundee, United Kingdom. His research primarily focuses on colorectal cancer risk prediction, Crohn's disease diagnostics, and the management of anti-TNF therapy. Recent publications explore biomarkers and treatment strategies for inflammatory bowel diseases, as well as advancements in diagnostic imaging techniques.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Robert JC Steele

Research Professor

UNITED KINGDOM

View details

Nicholas Kennedy

Honorary Clinical Senior Lecturer

University of Exeter

UNITED KINGDOM

View details

Stephen McSorley

Clinical Lecturer

University of Glasgow

UNITED KINGDOM

View details

James Lee

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Craig Mowat

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Response to

Combining faecal haemoglobin, iron deficiency anaemia status, and age can improve colorectal cancer risk prediction in patients attending primary care with bowel symptoms

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?

Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

Influence of diffusion weighted imaging and contrast enhanced T1 sequences on the diagnostic accuracy of magnetic resonance enterography for Crohn's disease

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease

Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients

Colon capsule endoscopy investigation based on faecal haemoglobin concentration in symptomatic patients to detect bowel disease

Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Impact of faecal haemoglobin-based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis

Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn’s Disease: Experience from the METRIC Trial

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.

Inflammatory bowel disease and cardiovascular diseases

Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker

Soft hybrid intrinsically motile robot for wireless small bowel enteroscopy

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST)

Collaborators (14)

Robert JC Steele

Nicholas Kennedy

Stephen McSorley

James Lee

J. R. Fraser Cummings

angus watson

Nick Powell

Shaji Sebastian

Gordon Moran

Callum G Fraser

Jonathan Macdonald

Vipul Jairath

Laura Quinn

Christopher A. Lamb

Make your next move.